Skip to main content
SpringerLink
Log in

Overview of vaccination policies for the elderly in Western European countries

  • Review Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Age-related changes in the immune system are associated with increased susceptibility to infections, greater disease severity and poorer outcomes in the elderly compared with young adults. Both influenza and pneumonia are important causes of morbidity and mortality in the elderly, and herpes zoster also represents an important disease burden in this population. Vaccinations against influenza and Streptococcus pneumoniae (pneumococcus) have been shown to reduce the incidence of influenza and invasive pneumococcal disease, respectively, in the elderly. In addition, as is the case with diphtheria/tetanus and herpes zoster vaccines, they can help to reduce the associated burden of disease in vaccinated individuals. Despite the evidence of these benefits, there are considerable variations among the countries of Western Europe in their policies for vaccination in the elderly. Western European countries face the prospect of a population in which the proportion of elderly people is increasing, with a consequent increase in demand on the healthcare system. Acknowledgement of the benefits of vaccination in the elderly, together with comprehensive vaccination policies for this age group, could help to reduce some of these demands.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002; 211: 659–66.

    Article  Google Scholar 

  2. Walford RL. The immunologic theory of aging. Munksgaard Press: Copenhagen; 1969.

    Google Scholar 

  3. Aspinall R, Del Giudice G, Effros RB, Grubeck-Loebenstein B, Sambhara S. Challenges for vaccination in the elderly. Immun Ageing 2007; 4: 9.

    Article  PubMed  Google Scholar 

  4. United Nations. World Population ageing 1950–2050. Department of Economic and Social Affairs, Population Division. 2002. Available at: http://www.un.org/esa/population/publications/worldageing19502050/ Accessed 10 December 2008.

  5. World Health Organization. Influenza vaccines. WHO position paper. Wkly Epidemiol Rec 2005; 80: 279–87.

    Google Scholar 

  6. World Health Organization. Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec 2008; 83: 373–84.

    Google Scholar 

  7. European Centre for Disease Prevention and Control. Seasonal Human Influenza and Vaccination — Fact sheet. Available at: http://ecdc.europa.eu/en/Health_Topics/Seasonal%20Influenza/factsheet_seasonal_vaccination.aspx. Accessed 18 February 2009.

  8. Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 2000; 30: 931–3.

    Article  PubMed  CAS  Google Scholar 

  9. Health Protection Agency. A Winter’s Tale. Coming to terms with winter respiratory illnesses. London, UK. 2005. Available at: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1196942154040. Accessed 10 December 2008.

  10. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661–5.

    CAS  Google Scholar 

  11. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 1995; 123: 518–27.

    Article  CAS  Google Scholar 

  12. Landi F, Onder G, Cesari M et al. Effects of influenza vaccination on mortality among frail, community-living elderly patients: an observational study. Aging Clin Exp Res 2003; 15: 254–8.

    Article  PubMed  Google Scholar 

  13. Nichol KL. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003; 21: 1769–75.

    Article  PubMed  Google Scholar 

  14. Ryan J, Zoellner Y, Gradl B, Palache B, Medema J. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. Vaccine 2006; 24: 6812–22.

    Article  PubMed  Google Scholar 

  15. World Health Organization. 56th World Health Assembly. Prevention and control of influenza pandemics and annual epidemics. 2003 (WHA56.19).

  16. Blank PR, Schwenkglenks M, Szucs TD. Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC Public Health 2008; 8: 272 doi:10.1186/1471-2458-8-272.

    Article  PubMed  Google Scholar 

  17. Mereckiene J, Cotter S, Nicoll A et al. National seasonal influenza vaccination survey in Europe, 2008. Eurosurveillance 2008;13: 4–10.

    Google Scholar 

  18. Rothan-Tondeur M, de Wazieres B, Lejeune B, Gavazzi G. Influenza vaccine coverage for healthcare workers in geriatric settings in France. Aging Clin Exp Res 2006; 18: 512–26.

    Article  PubMed  Google Scholar 

  19. Artz AS, Ershler WB, Longo DL. Pneumococcal vaccination and revaccination of older adults. Clin Microbiol Rev 2003; 16: 308–18.

    Article  PubMed  Google Scholar 

  20. World Health Organization. Pneumococcal vaccines. WHO position paper. Wkly Epidemiol Rec 2003b; 78: 110–9.

    Google Scholar 

  21. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006; 19: 571–82.

    Article  PubMed  CAS  Google Scholar 

  22. Kyaw MH, Christie P, Clarke SC et al. Invasive pneumococcal disease in Scotland in 1999–2001: Use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 2003; 37: 1283–91.

    Article  PubMed  Google Scholar 

  23. Centre National de Référence des Pneumocoques. Rapport d’activité de 2006. Available at: http://www.invs.sante.fr/surveillance/cnr/rapport_cnr_pneumo_2006.pdf

  24. Sahm DF, Brown NP, Thornsberry C, Jones ME. Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective. Postgrad Med 2008; 120 (3 Suppl 1): 16–24.

    Article  PubMed  Google Scholar 

  25. Fedson D, Liss C. Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults. Vaccine 2004; 22: 927–46.

    Article  PubMed  CAS  Google Scholar 

  26. Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008, Issue 1. Art. No.: CD000422. DOI: 10.1002/14651858.CD000422.pub2.

  27. Evers SM, Ament AJ, Colombo GL et al. Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries. Eur J Clin Microbiol Infect Dis 2007; 26: 531–40.

    Article  PubMed  CAS  Google Scholar 

  28. Christenson B, Pauksen K, Sylvan SPE. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virol J 2008; 5: 52.

    Article  PubMed  Google Scholar 

  29. Rey M, Patey O, Vincent-Ballereau F. Diphtheria’s European come back. Euro Surveill. 1996;1(2):pii=132. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=132

  30. Neal S, Efstratiou A. DIPNET — establishment of a dedicated surveillance network for diphtheria in Europe. Euro Surveill. 2007; 12(12): E9–E10. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=754

    PubMed  CAS  Google Scholar 

  31. Hainz U, Jenewein B, Asch E, Pfeiffer KP, Berger P, Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 2005; 23: 3232–5.

    Article  PubMed  Google Scholar 

  32. Wareham DW, Breuer J. Herpes zoster. BMJ 2007; 334:1211–5.

    Article  PubMed  Google Scholar 

  33. Hope-Simpson RE. The nature of herpes zoster: a long term study and a new hypothesis. Proc R Soc Med 1965; 58: 9–20.

    PubMed  CAS  Google Scholar 

  34. Hope-Simpson RE. Postherpetic neuralgia. J R Coll Gen Pract 1975; 25: 571–5.

    PubMed  CAS  Google Scholar 

  35. Gauthier A, Breuer J, Carrington D, Martin M, Rémy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009; 137: 38–47.

    Article  PubMed  CAS  Google Scholar 

  36. Johnson RW, Wasner G, Saddier P, Baron R. Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother 2007; 7: 1581–95.

    Article  PubMed  CAS  Google Scholar 

  37. Oxman MN, Levin MJ, Johnson GR et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 2005; 352: 2271–84.

    Article  PubMed  CAS  Google Scholar 

  38. Zostavax. Summary of Product Characteristics. Sanofi Pasteur MSD, Lyon, France, 2007.

  39. Harpaz R, Ortega-Sanchez IR, Seward JF. Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2008; 57(RR-5): 1–30.

    PubMed  Google Scholar 

  40. Bundesministerium für Gesundheit.

  41. Szucs TD, Muller D. Influenza vaccination coverage rates in five European countries — a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 2005; 23: 5055–63.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sanofi Pasteur MSD, 8 rue Jonas Salk, 69367, Lyon cedex 07, France

    Sandrine I. Samson & Yves Mégard MD

Authors
  1. Sandrine I. Samson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yves Mégard MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yves Mégard MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Samson, S.I., Mégard, Y. Overview of vaccination policies for the elderly in Western European countries. Aging Clin Exp Res 21, 210–215 (2009). https://doi.org/10.1007/BF03324912

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03324912

Keywords

Search

Navigation